stock
LGNYZ · LIGAND PHARMACEUTICALS INC
What LIGAND PHARMACEUTICALS INC reports to the SEC, read from its filings.
Open in the appPrice
The live LGNYZ price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on LGNYZ.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 19,935,609 as of 2026-08-04 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- 32.6%
- Net
- 67.9%
Returns
- ROE
- 20.4%
- ROA
- 9.0%
Health
- Current ratio
- 31.2x
- Debt/equity
- 1.2x
Deep value
- NCAV
- $238.76M
- NCAV per share
- $11.98
- Price/NCAV
- Locked
- NNWC
- -$156.27M
- NNWC per share
- -$7.84
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $63.69M | —Gross profit: unreported by this company. | $8.59M | $48.51M | 10-Q filed 2026-08-07 |
| 2026-03-31 | $51.72M | —Gross profit: unreported by this company. | $17.37M | -$13.35M | 10-Q filed 2026-08-07 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $59.67M | —Gross profit: unreported by this company. | $13.84M | $44.78M | DEF 14A filed 2026-04-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $115.46M | —Gross profit: unreported by this company. | $54.93M | $117.27M | 10-Q filed 2025-11-07 |
| 2025-06-30 | $47.63M | —Gross profit: unreported by this company. | $8.44M | $4.85M | 10-Q filed 2026-08-07 |
| 2025-03-31 | $45.33M | —Gross profit: unreported by this company. | -$36.22M | -$42.45M | 10-Q filed 2026-05-08 |
| 2024-12-31 | $42.81M | —Gross profit: unreported by this company. | -$9.64M | -$31.09M | DEF 14A filed 2026-04-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $51.81M | —Gross profit: unreported by this company. | $3.14M | -$7.17M | 10-Q filed 2025-11-07 |
- Assets
- $2.19B
- Equity
- $967.52M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $268.09M | $41.00M | $124.45M | $48.91M |
| 2024-12-31 | $167.13M | -$22.61M | -$4.03M | $95.23M |
| 2023-12-31 | $131.31M | $11.94M | $52.15M | $46.06M |
| 2022-12-31 | $196.25M | $3.04M | -$33.36M | $119.93M |
| 2021-12-31 | $241.54M | $103.85M | $57.14M | $70.04M |
| 2020-12-31 | $163.56M | $37.50M | -$2.98M | $50.13M |
| 2019-12-31 | $120.28M | $807.08M | $629.30M | -$31.89M |
| 2018-12-31 | $251.45M | $163.73M | $143.32M | $193.17M |
| 2017-12-31 | $141.10M | $68.08M | $12.56M | $86.41M |
| 2016-12-31 | $108.97M | $43.88M | -$1.64M | $58.88M |
Company filings
since Fri Feb 27
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 248-KRegulation FD disclosure
Regulation FD disclosureSep 228-K8-K
Sep 28-K/AResults
ResultsAug 68-KMaterial agreement, Acquisition or sale completed, New debt, Regulation FD disclosure
Material agreementAcquisition or sale completedNew debtRegulation FD disclosureJul 148-KMaterial agreement, New debt, Unregistered share sale, Other event
Material agreementNew debtUnregistered share saleOther eventJun 258-K
5% owners ()
Invesco Ltd.
Passive stake
Vanguard Portfolio Management
Passive stake
Vanguard Capital Management
Passive stake
The Vanguard Group
Stake update
JANUS HENDERSON GROUP PLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named LGNYZ, and the market events around them.
Sign in to see thisBoard
The LGNYZ board could not be loaded.
Retry the LGNYZ boardnakagai
Signals on LGNYZ come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the LGNYZ board